Capturing Pediatric Health and Medication Use in a US National Health Data Network

Area of Science:

• Pediatric pharmacology
• Real-world data analytics
• Drug safety surveillance

Background:

• Traditional methods for assessing pediatric medication safety have limitations.
• Real-world data (RWD) offers a valuable alternative for enhancing safety assessments.
• The Sentinel Distributed Database (SDD) is a key RWD resource.

Purpose of the Study:

• To characterize the demographics, enrollment, and health profiles of pediatric members within the SDD.
• To evaluate the SDD's utility for pediatric medication safety research.

Main Methods:

• Utilized administrative healthcare data from the SDD (2000-2023).
• Employed descriptive statistics to analyze pediatric populations across defined age groups.
• Included infants, young children, older children, early adolescents, and late adolescents.

Main Results:

• Older children (6-12 years) comprised the largest group (>46 million members).
• Other age groups ranged from 27.5 to 45.4 million members.
• Prevalent health conditions and medication use aligned with national estimates.

Conclusions:

• The FDA's Sentinel Distributed Database accurately reflects pediatric health characteristics.
• The SDD serves as a valuable adjunct for monitoring medical product safety in US children.
• RWD in the SDD supports robust pediatric drug safety evaluations.